| Name | Title | Contact Details |
|---|
For over 120 years, Parr Instrument Company has been designing, manufacturing, and selling high quality laboratory instruments and apparatus for conducting chemical reactions and tests under heat and pressure and for testing fuels. Parrs extensive product line includes stirred reactors, pressure vessels, and high pressure tubular reactors for the study of catalytic and non-catalytic reactions in batch, continuous-flow, and multiple/parallel operation for the chemical, polymer, biofuels, hydrometallurgical, pharmaceutical, petroleum, and petrochemical industries. Custom designed complex reactor systems, built to the customers specifications and requirements are also provided. Parrs oxygen combustion calorimeters are used for the determination of the heat of combustion in solid, liquid, and refuse-derived fuels for the energy, educational, coal, and fuel testing industries. Parr also offers sample preparation vessels for extraction, digestion, and hydrothermal synthesis, as well as a line of vessels for cell disruption by nitrogen decompression.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
Tower Street Insurance was established to provide the most effective solutions to manage your commercial and personal risks. It is our privilege to represent and partner with each of our clients. We have built our reputation on offering successful families and businesses the highest level of service rooted in transparency and trust. With our extensive resources and exclusive carrier options, we are able to create protection strategies that provide custom solutions with the broadest coverage, superior claims service, and overall best value. However, we also understand that choosing a risk management solution involves more than simply obtaining coverage, so we go beyond offering policies backed by the best insurance companies in the business. We listen to specific needs, form solid relationships, and take the time to walk each client through all aspects of their personalized insurance plan. After the plan is in place, we continue to serve as an on-call partner devoted to our clients risk management success year-round. At Tower Street Insurance, our entire team is passionate about providing a consistently exceptional experience. Our commitment to perfection, attention to detail, and many years in the industry allow us to confidently provide a solution for all risk management and insurance needs. We hope we will have the opportunity to provide a comprehensive insurance solution for your business and family.
One platform. Endless solutions.